As per the latest Enforcement Report by Food and Drug Administration (USFDA), the US-based subsidiary of Dr Reddy's ...
Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according ...
MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved ...
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...
An updated evidence-based guideline aimed at helping clinicians and other health care providers manage patients with opioid ...